Similar articles

• How should intravenous thrombolytic agents for acute myocardial infarction be selected?

  Topol EJ. Topol EJ. Cardiovasc Clin. 1990;21(1):57-75; discussion 76-8. Cardiovasc Clin. 1990. PMID: 2143103 No abstract available.
• Thrombolytic treatment in acute myocardial infarction.

  Acar J, Vahanian A, Michel PL, Slama M, Cormier B, Roger V. Acar J, et al. Semin Thromb Hemost. 1987 Apr;13(2):186-200. doi: 10.1055/s-2007-1003492. Semin Thromb Hemost. 1987. PMID: 2957791 Review. No abstract available.
• [The choice of appropriate thrombolytic agents as therapy in acute heart infarct].

  Görge G, Meyer J. Görge G, et al. Med Klin (Munich). 1992 Feb 15;87(2):70-80, 108. Med Klin (Munich). 1992. PMID: 1542286 Review. German. No abstract available.
• [Thrombolysis in acute myocardial infarct: prerequisites, current experiences and remaining problems].

  Rapold HJ. Rapold HJ. Schweiz Med Wochenschr. 1986 Aug 16;116(33):1074-87. Schweiz Med Wochenschr. 1986. PMID: 3094141 Review. German.
• Pulmonary embolism thrombolysis: Do we need another agent?

  Goldhaber SZ. Goldhaber SZ. Am Heart J. 1999 Jul;138(1 Pt 1):1-2. doi: 10.1016/s0002-8703(99)70233-4. Am Heart J. 1999. PMID: 10385751 No abstract available.